nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00495	0.00496	CcSEcCtD
Perflutren—Face oedema—Temozolomide—melanoma	0.0048	0.00481	CcSEcCtD
Perflutren—Hearing impaired—Docetaxel—melanoma	0.00478	0.00479	CcSEcCtD
Perflutren—Anaphylactic shock—Vemurafenib—melanoma	0.00478	0.00479	CcSEcCtD
Perflutren—Nervous system disorder—Vemurafenib—melanoma	0.00469	0.0047	CcSEcCtD
Perflutren—Skin disorder—Vemurafenib—melanoma	0.00464	0.00465	CcSEcCtD
Perflutren—Dry skin—Temozolomide—melanoma	0.00455	0.00456	CcSEcCtD
Perflutren—Injection site reaction—Docetaxel—melanoma	0.00453	0.00453	CcSEcCtD
Perflutren—Hypotension—Vemurafenib—melanoma	0.00447	0.00447	CcSEcCtD
Perflutren—Influenza like illness—Docetaxel—melanoma	0.00442	0.00443	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00435	0.00436	CcSEcCtD
Perflutren—Sweating increased—Temozolomide—melanoma	0.00418	0.00419	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vemurafenib—melanoma	0.00413	0.00413	CcSEcCtD
Perflutren—Fatigue—Vemurafenib—melanoma	0.00412	0.00413	CcSEcCtD
Perflutren—Haemoglobin—Bleomycin—melanoma	0.0041	0.0041	CcSEcCtD
Perflutren—Haemorrhage—Bleomycin—melanoma	0.00407	0.00408	CcSEcCtD
Perflutren—Hypoaesthesia—Bleomycin—melanoma	0.00405	0.00406	CcSEcCtD
Perflutren—Neuropathy peripheral—Carmustine—melanoma	0.00388	0.00389	CcSEcCtD
Perflutren—Flushing—Bleomycin—melanoma	0.00378	0.00379	CcSEcCtD
Perflutren—Body temperature increased—Vemurafenib—melanoma	0.00378	0.00378	CcSEcCtD
Perflutren—Pharyngitis—Dactinomycin—melanoma	0.00377	0.00378	CcSEcCtD
Perflutren—Neuropathy peripheral—Temozolomide—melanoma	0.00375	0.00376	CcSEcCtD
Perflutren—Swelling—Docetaxel—melanoma	0.00375	0.00375	CcSEcCtD
Perflutren—Chills—Bleomycin—melanoma	0.00366	0.00366	CcSEcCtD
Perflutren—Cardiac failure congestive—Docetaxel—melanoma	0.00364	0.00365	CcSEcCtD
Perflutren—Haemoglobin—Carmustine—melanoma	0.00358	0.00358	CcSEcCtD
Perflutren—Haemorrhage—Carmustine—melanoma	0.00356	0.00356	CcSEcCtD
Perflutren—Erythema—Bleomycin—melanoma	0.00355	0.00355	CcSEcCtD
Perflutren—Hypoaesthesia—Carmustine—melanoma	0.00354	0.00355	CcSEcCtD
Perflutren—Hot flush—Docetaxel—melanoma	0.00353	0.00354	CcSEcCtD
Perflutren—Flushing—Dactinomycin—melanoma	0.00353	0.00353	CcSEcCtD
Perflutren—Hypersensitivity—Vemurafenib—melanoma	0.00352	0.00353	CcSEcCtD
Perflutren—Menopausal symptoms—Docetaxel—melanoma	0.0035	0.00351	CcSEcCtD
Perflutren—Connective tissue disorder—Carmustine—melanoma	0.0035	0.0035	CcSEcCtD
Perflutren—Visual disturbance—Docetaxel—melanoma	0.00349	0.00349	CcSEcCtD
Perflutren—Atrial fibrillation—Docetaxel—melanoma	0.00349	0.00349	CcSEcCtD
Perflutren—Haemoglobin—Temozolomide—melanoma	0.00345	0.00346	CcSEcCtD
Perflutren—Haemorrhage—Temozolomide—melanoma	0.00344	0.00344	CcSEcCtD
Perflutren—Asthenia—Vemurafenib—melanoma	0.00343	0.00344	CcSEcCtD
Perflutren—Visual impairment—Carmustine—melanoma	0.00343	0.00343	CcSEcCtD
Perflutren—Hypoaesthesia—Temozolomide—melanoma	0.00342	0.00343	CcSEcCtD
Perflutren—Pharyngitis—Temozolomide—melanoma	0.00341	0.00342	CcSEcCtD
Perflutren—Chills—Dactinomycin—melanoma	0.00341	0.00342	CcSEcCtD
Perflutren—Pruritus—Vemurafenib—melanoma	0.00338	0.00339	CcSEcCtD
Perflutren—Connective tissue disorder—Temozolomide—melanoma	0.00338	0.00338	CcSEcCtD
Perflutren—Eye disorder—Carmustine—melanoma	0.00332	0.00333	CcSEcCtD
Perflutren—Visual impairment—Temozolomide—melanoma	0.00331	0.00332	CcSEcCtD
Perflutren—Erythema—Dactinomycin—melanoma	0.00331	0.00331	CcSEcCtD
Perflutren—Flushing—Carmustine—melanoma	0.0033	0.00331	CcSEcCtD
Perflutren—Ill-defined disorder—Bleomycin—melanoma	0.00329	0.0033	CcSEcCtD
Perflutren—Diarrhoea—Vemurafenib—melanoma	0.00327	0.00328	CcSEcCtD
Perflutren—Eye disorder—Temozolomide—melanoma	0.00321	0.00322	CcSEcCtD
Perflutren—Tinnitus—Temozolomide—melanoma	0.0032	0.00321	CcSEcCtD
Perflutren—Malaise—Bleomycin—melanoma	0.0032	0.00321	CcSEcCtD
Perflutren—Cardiac disorder—Temozolomide—melanoma	0.00319	0.0032	CcSEcCtD
Perflutren—Flushing—Temozolomide—melanoma	0.00319	0.0032	CcSEcCtD
Perflutren—Arrhythmia—Carmustine—melanoma	0.00318	0.00318	CcSEcCtD
Perflutren—Leukopenia—Bleomycin—melanoma	0.00318	0.00318	CcSEcCtD
Perflutren—Dizziness—Vemurafenib—melanoma	0.00316	0.00317	CcSEcCtD
Perflutren—Angiopathy—Temozolomide—melanoma	0.00312	0.00312	CcSEcCtD
Perflutren—Immune system disorder—Temozolomide—melanoma	0.0031	0.00311	CcSEcCtD
Perflutren—Mediastinal disorder—Temozolomide—melanoma	0.0031	0.0031	CcSEcCtD
Perflutren—Erythema—Carmustine—melanoma	0.0031	0.0031	CcSEcCtD
Perflutren—Cough—Bleomycin—melanoma	0.0031	0.0031	CcSEcCtD
Perflutren—Chills—Temozolomide—melanoma	0.00308	0.00309	CcSEcCtD
Perflutren—Ill-defined disorder—Dactinomycin—melanoma	0.00307	0.00308	CcSEcCtD
Perflutren—Vomiting—Vemurafenib—melanoma	0.00304	0.00304	CcSEcCtD
Perflutren—Dry skin—Docetaxel—melanoma	0.00303	0.00303	CcSEcCtD
Perflutren—Chest pain—Bleomycin—melanoma	0.00302	0.00303	CcSEcCtD
Perflutren—Myalgia—Bleomycin—melanoma	0.00302	0.00303	CcSEcCtD
Perflutren—Rash—Vemurafenib—melanoma	0.00301	0.00302	CcSEcCtD
Perflutren—Dermatitis—Vemurafenib—melanoma	0.00301	0.00302	CcSEcCtD
Perflutren—Back pain—Carmustine—melanoma	0.003	0.003	CcSEcCtD
Perflutren—Headache—Vemurafenib—melanoma	0.00299	0.003	CcSEcCtD
Perflutren—Erythema—Temozolomide—melanoma	0.00299	0.003	CcSEcCtD
Perflutren—Discomfort—Bleomycin—melanoma	0.00298	0.00299	CcSEcCtD
Perflutren—Malaise—Dactinomycin—melanoma	0.00298	0.00299	CcSEcCtD
Perflutren—Cramp muscle—Docetaxel—melanoma	0.00298	0.00298	CcSEcCtD
Perflutren—Leukopenia—Dactinomycin—melanoma	0.00296	0.00297	CcSEcCtD
Perflutren—Dysgeusia—Temozolomide—melanoma	0.00293	0.00294	CcSEcCtD
Perflutren—Vision blurred—Carmustine—melanoma	0.00292	0.00292	CcSEcCtD
Perflutren—Tremor—Carmustine—melanoma	0.0029	0.00291	CcSEcCtD
Perflutren—Oedema—Bleomycin—melanoma	0.0029	0.0029	CcSEcCtD
Perflutren—Anaphylactic shock—Bleomycin—melanoma	0.0029	0.0029	CcSEcCtD
Perflutren—Back pain—Temozolomide—melanoma	0.00289	0.0029	CcSEcCtD
Perflutren—Agitation—Carmustine—melanoma	0.00285	0.00285	CcSEcCtD
Perflutren—Nausea—Vemurafenib—melanoma	0.00284	0.00284	CcSEcCtD
Perflutren—Vision blurred—Temozolomide—melanoma	0.00282	0.00283	CcSEcCtD
Perflutren—Myalgia—Dactinomycin—melanoma	0.00282	0.00282	CcSEcCtD
Perflutren—Bronchospasm—Docetaxel—melanoma	0.00281	0.00281	CcSEcCtD
Perflutren—Tremor—Temozolomide—melanoma	0.0028	0.00281	CcSEcCtD
Perflutren—Discomfort—Dactinomycin—melanoma	0.00278	0.00279	CcSEcCtD
Perflutren—Ill-defined disorder—Temozolomide—melanoma	0.00278	0.00278	CcSEcCtD
Perflutren—Leukopenia—Carmustine—melanoma	0.00277	0.00278	CcSEcCtD
Perflutren—Agitation—Temozolomide—melanoma	0.00275	0.00276	CcSEcCtD
Perflutren—Angioedema—Temozolomide—melanoma	0.00273	0.00274	CcSEcCtD
Perflutren—Hypotension—Bleomycin—melanoma	0.00271	0.00271	CcSEcCtD
Perflutren—Oedema—Dactinomycin—melanoma	0.0027	0.00271	CcSEcCtD
Perflutren—Malaise—Temozolomide—melanoma	0.0027	0.0027	CcSEcCtD
Perflutren—Vertigo—Temozolomide—melanoma	0.00269	0.00269	CcSEcCtD
Perflutren—Convulsion—Carmustine—melanoma	0.00268	0.00269	CcSEcCtD
Perflutren—Leukopenia—Temozolomide—melanoma	0.00268	0.00268	CcSEcCtD
Perflutren—Hypertension—Carmustine—melanoma	0.00267	0.00268	CcSEcCtD
Perflutren—Palpitations—Temozolomide—melanoma	0.00264	0.00265	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Bleomycin—melanoma	0.00264	0.00264	CcSEcCtD
Perflutren—Chest pain—Carmustine—melanoma	0.00264	0.00264	CcSEcCtD
Perflutren—Myalgia—Carmustine—melanoma	0.00264	0.00264	CcSEcCtD
Perflutren—Cough—Temozolomide—melanoma	0.00261	0.00262	CcSEcCtD
Perflutren—Paraesthesia—Bleomycin—melanoma	0.0026	0.0026	CcSEcCtD
Perflutren—Convulsion—Temozolomide—melanoma	0.00259	0.0026	CcSEcCtD
Perflutren—Hypertension—Temozolomide—melanoma	0.00258	0.00259	CcSEcCtD
Perflutren—Dyspnoea—Bleomycin—melanoma	0.00258	0.00259	CcSEcCtD
Perflutren—Myalgia—Temozolomide—melanoma	0.00255	0.00255	CcSEcCtD
Perflutren—Arthralgia—Temozolomide—melanoma	0.00255	0.00255	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00253	0.00253	CcSEcCtD
Perflutren—Oedema—Carmustine—melanoma	0.00253	0.00253	CcSEcCtD
Perflutren—Discomfort—Temozolomide—melanoma	0.00252	0.00252	CcSEcCtD
Perflutren—Neuropathy peripheral—Docetaxel—melanoma	0.0025	0.0025	CcSEcCtD
Perflutren—Dry mouth—Temozolomide—melanoma	0.00249	0.0025	CcSEcCtD
Perflutren—Pain—Bleomycin—melanoma	0.00248	0.00248	CcSEcCtD
Perflutren—Conjunctivitis—Docetaxel—melanoma	0.00248	0.00248	CcSEcCtD
Perflutren—Tachycardia—Carmustine—melanoma	0.00247	0.00247	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00246	0.00246	CcSEcCtD
Perflutren—Oedema—Temozolomide—melanoma	0.00244	0.00245	CcSEcCtD
Perflutren—Anaphylactic shock—Temozolomide—melanoma	0.00244	0.00245	CcSEcCtD
Perflutren—Nervous system disorder—Temozolomide—melanoma	0.00239	0.0024	CcSEcCtD
Perflutren—Feeling abnormal—Bleomycin—melanoma	0.00239	0.00239	CcSEcCtD
Perflutren—Skin disorder—Temozolomide—melanoma	0.00237	0.00238	CcSEcCtD
Perflutren—Hypotension—Carmustine—melanoma	0.00236	0.00237	CcSEcCtD
Perflutren—Hyperhidrosis—Temozolomide—melanoma	0.00236	0.00237	CcSEcCtD
Perflutren—Fatigue—Dactinomycin—melanoma	0.00233	0.00233	CcSEcCtD
Perflutren—Pain—Dactinomycin—melanoma	0.00231	0.00231	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Carmustine—melanoma	0.0023	0.00231	CcSEcCtD
Perflutren—Urticaria—Bleomycin—melanoma	0.0023	0.0023	CcSEcCtD
Perflutren—Haemoglobin—Docetaxel—melanoma	0.0023	0.0023	CcSEcCtD
Perflutren—Rhinitis—Docetaxel—melanoma	0.00229	0.0023	CcSEcCtD
Perflutren—Body temperature increased—Bleomycin—melanoma	0.00229	0.00229	CcSEcCtD
Perflutren—Haemorrhage—Docetaxel—melanoma	0.00229	0.00229	CcSEcCtD
Perflutren—Hypoaesthesia—Docetaxel—melanoma	0.00227	0.00228	CcSEcCtD
Perflutren—Paraesthesia—Carmustine—melanoma	0.00227	0.00227	CcSEcCtD
Perflutren—Pharyngitis—Docetaxel—melanoma	0.00227	0.00227	CcSEcCtD
Perflutren—Dyspnoea—Carmustine—melanoma	0.00225	0.00226	CcSEcCtD
Perflutren—Connective tissue disorder—Docetaxel—melanoma	0.00225	0.00225	CcSEcCtD
Perflutren—Feeling abnormal—Dactinomycin—melanoma	0.00223	0.00223	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Temozolomide—melanoma	0.00222	0.00223	CcSEcCtD
Perflutren—Gastrointestinal pain—Dactinomycin—melanoma	0.00221	0.00221	CcSEcCtD
Perflutren—Visual impairment—Docetaxel—melanoma	0.0022	0.00221	CcSEcCtD
Perflutren—Paraesthesia—Temozolomide—melanoma	0.00219	0.0022	CcSEcCtD
Perflutren—Gastrointestinal disorder—Carmustine—melanoma	0.00218	0.00219	CcSEcCtD
Perflutren—Dyspnoea—Temozolomide—melanoma	0.00218	0.00218	CcSEcCtD
Perflutren—Pain—Carmustine—melanoma	0.00216	0.00217	CcSEcCtD
Perflutren—Dyspepsia—Temozolomide—melanoma	0.00215	0.00215	CcSEcCtD
Perflutren—Eye disorder—Docetaxel—melanoma	0.00214	0.00214	CcSEcCtD
Perflutren—Body temperature increased—Dactinomycin—melanoma	0.00213	0.00214	CcSEcCtD
Perflutren—Abdominal pain—Dactinomycin—melanoma	0.00213	0.00214	CcSEcCtD
Perflutren—Hypersensitivity—Bleomycin—melanoma	0.00213	0.00214	CcSEcCtD
Perflutren—Cardiac disorder—Docetaxel—melanoma	0.00212	0.00213	CcSEcCtD
Perflutren—Flushing—Docetaxel—melanoma	0.00212	0.00213	CcSEcCtD
Perflutren—Gastrointestinal disorder—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Perflutren—Fatigue—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Perflutren—Pain—Temozolomide—melanoma	0.00209	0.00209	CcSEcCtD
Perflutren—Feeling abnormal—Carmustine—melanoma	0.00208	0.00209	CcSEcCtD
Perflutren—Asthenia—Bleomycin—melanoma	0.00208	0.00208	CcSEcCtD
Perflutren—Angiopathy—Docetaxel—melanoma	0.00207	0.00208	CcSEcCtD
Perflutren—Gastrointestinal pain—Carmustine—melanoma	0.00207	0.00207	CcSEcCtD
Perflutren—Immune system disorder—Docetaxel—melanoma	0.00206	0.00207	CcSEcCtD
Perflutren—Mediastinal disorder—Docetaxel—melanoma	0.00206	0.00206	CcSEcCtD
Perflutren—Chills—Docetaxel—melanoma	0.00205	0.00206	CcSEcCtD
Perflutren—Pruritus—Bleomycin—melanoma	0.00205	0.00205	CcSEcCtD
Perflutren—Arrhythmia—Docetaxel—melanoma	0.00204	0.00205	CcSEcCtD
Perflutren—Feeling abnormal—Temozolomide—melanoma	0.00201	0.00202	CcSEcCtD
Perflutren—Abdominal pain—Carmustine—melanoma	0.002	0.002	CcSEcCtD
Perflutren—Body temperature increased—Carmustine—melanoma	0.002	0.002	CcSEcCtD
Perflutren—Gastrointestinal pain—Temozolomide—melanoma	0.002	0.002	CcSEcCtD
Perflutren—Erythema—Docetaxel—melanoma	0.00199	0.00199	CcSEcCtD
Perflutren—Hypersensitivity—Dactinomycin—melanoma	0.00199	0.00199	CcSEcCtD
Perflutren—Dysgeusia—Docetaxel—melanoma	0.00195	0.00195	CcSEcCtD
Perflutren—Urticaria—Temozolomide—melanoma	0.00194	0.00194	CcSEcCtD
Perflutren—Asthenia—Dactinomycin—melanoma	0.00194	0.00194	CcSEcCtD
Perflutren—Abdominal pain—Temozolomide—melanoma	0.00193	0.00193	CcSEcCtD
Perflutren—Body temperature increased—Temozolomide—melanoma	0.00193	0.00193	CcSEcCtD
Perflutren—Back pain—Docetaxel—melanoma	0.00192	0.00193	CcSEcCtD
Perflutren—Sevoflurane—ALB—melanoma	0.00192	1	CrCbGaD
Perflutren—Muscle spasms—Docetaxel—melanoma	0.00191	0.00192	CcSEcCtD
Perflutren—Hypersensitivity—Carmustine—melanoma	0.00186	0.00187	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—melanoma	0.00185	0.00185	CcSEcCtD
Perflutren—Vomiting—Bleomycin—melanoma	0.00184	0.00184	CcSEcCtD
Perflutren—Rash—Bleomycin—melanoma	0.00183	0.00183	CcSEcCtD
Perflutren—Dermatitis—Bleomycin—melanoma	0.00182	0.00183	CcSEcCtD
Perflutren—Asthenia—Carmustine—melanoma	0.00181	0.00182	CcSEcCtD
Perflutren—Hypersensitivity—Temozolomide—melanoma	0.0018	0.0018	CcSEcCtD
Perflutren—Syncope—Docetaxel—melanoma	0.00178	0.00179	CcSEcCtD
Perflutren—Leukopenia—Docetaxel—melanoma	0.00178	0.00178	CcSEcCtD
Perflutren—Palpitations—Docetaxel—melanoma	0.00176	0.00176	CcSEcCtD
Perflutren—Asthenia—Temozolomide—melanoma	0.00175	0.00176	CcSEcCtD
Perflutren—Loss of consciousness—Docetaxel—melanoma	0.00175	0.00175	CcSEcCtD
Perflutren—Cough—Docetaxel—melanoma	0.00174	0.00174	CcSEcCtD
Perflutren—Diarrhoea—Carmustine—melanoma	0.00173	0.00173	CcSEcCtD
Perflutren—Pruritus—Temozolomide—melanoma	0.00173	0.00173	CcSEcCtD
Perflutren—Convulsion—Docetaxel—melanoma	0.00172	0.00173	CcSEcCtD
Perflutren—Nausea—Bleomycin—melanoma	0.00172	0.00172	CcSEcCtD
Perflutren—Hypertension—Docetaxel—melanoma	0.00172	0.00172	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—melanoma	0.00172	0.00172	CcSEcCtD
Perflutren—Rash—Dactinomycin—melanoma	0.0017	0.00171	CcSEcCtD
Perflutren—Myalgia—Docetaxel—melanoma	0.00169	0.0017	CcSEcCtD
Perflutren—Arthralgia—Docetaxel—melanoma	0.00169	0.0017	CcSEcCtD
Perflutren—Chest pain—Docetaxel—melanoma	0.00169	0.0017	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00168	0.00169	CcSEcCtD
Perflutren—Dizziness—Carmustine—melanoma	0.00167	0.00167	CcSEcCtD
Perflutren—Diarrhoea—Temozolomide—melanoma	0.00167	0.00167	CcSEcCtD
Perflutren—Dry mouth—Docetaxel—melanoma	0.00166	0.00166	CcSEcCtD
Perflutren—Oedema—Docetaxel—melanoma	0.00162	0.00163	CcSEcCtD
Perflutren—Anaphylactic shock—Docetaxel—melanoma	0.00162	0.00163	CcSEcCtD
Perflutren—Dizziness—Temozolomide—melanoma	0.00161	0.00162	CcSEcCtD
Perflutren—Vomiting—Carmustine—melanoma	0.00161	0.00161	CcSEcCtD
Perflutren—Nausea—Dactinomycin—melanoma	0.0016	0.00161	CcSEcCtD
Perflutren—Shock—Docetaxel—melanoma	0.0016	0.0016	CcSEcCtD
Perflutren—Rash—Carmustine—melanoma	0.00159	0.0016	CcSEcCtD
Perflutren—Nervous system disorder—Docetaxel—melanoma	0.00159	0.0016	CcSEcCtD
Perflutren—Dermatitis—Carmustine—melanoma	0.00159	0.00159	CcSEcCtD
Perflutren—Tachycardia—Docetaxel—melanoma	0.00159	0.00159	CcSEcCtD
Perflutren—Headache—Carmustine—melanoma	0.00158	0.00159	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—melanoma	0.00158	0.00158	CcSEcCtD
Perflutren—Vomiting—Temozolomide—melanoma	0.00155	0.00156	CcSEcCtD
Perflutren—Rash—Temozolomide—melanoma	0.00154	0.00154	CcSEcCtD
Perflutren—Dermatitis—Temozolomide—melanoma	0.00154	0.00154	CcSEcCtD
Perflutren—Headache—Temozolomide—melanoma	0.00153	0.00153	CcSEcCtD
Perflutren—Hypotension—Docetaxel—melanoma	0.00152	0.00152	CcSEcCtD
Perflutren—Nausea—Carmustine—melanoma	0.0015	0.0015	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—melanoma	0.00148	0.00148	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—melanoma	0.00146	0.00146	CcSEcCtD
Perflutren—Nausea—Temozolomide—melanoma	0.00145	0.00145	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—melanoma	0.00145	0.00145	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—melanoma	0.00143	0.00143	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Perflutren—Fatigue—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Perflutren—Pain—Docetaxel—melanoma	0.00139	0.00139	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—melanoma	0.00134	0.00134	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—melanoma	0.00133	0.00133	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—melanoma	0.00128	0.00129	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—melanoma	0.00128	0.00129	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—melanoma	0.0012	0.0012	CcSEcCtD
Perflutren—Asthenia—Docetaxel—melanoma	0.00117	0.00117	CcSEcCtD
Perflutren—Pruritus—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—melanoma	0.00111	0.00111	CcSEcCtD
Perflutren—Dizziness—Docetaxel—melanoma	0.00107	0.00108	CcSEcCtD
Perflutren—Vomiting—Docetaxel—melanoma	0.00103	0.00103	CcSEcCtD
Perflutren—Rash—Docetaxel—melanoma	0.00102	0.00103	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—melanoma	0.00102	0.00103	CcSEcCtD
Perflutren—Headache—Docetaxel—melanoma	0.00102	0.00102	CcSEcCtD
Perflutren—Nausea—Docetaxel—melanoma	0.000965	0.000967	CcSEcCtD
